Clinical Trial Update: Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating the efficacy and safety of PF-06741086 in adults and teens with Hemophilia A or Hemophilia B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• PF-06741086

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A, Hemophilia B | Phase 3 | Status: COMPLETED